The United States Food and Drug Administration has authorized the use of ONE Condoms during anal intercourse to reduce sexually transmitted infections. This is the first time the agency has approved a condom specifically for use during anal sex.
“The risk of STI transmission during anal intercourse is significantly higher than during vaginal intercourse,” says Courtney Lias, director of the FDA’s office of GastroRenal, ObGyn, General Hospital, and Urology Devices in a statement. “The FDA’s authorization of a condom that is specifically indicated, evaluated and labeled for anal intercourse may improve the likelihood of condom use during anal intercourse.”
Condoms need to have less than a five percent failure rate for authorization, and earlier studies have shown higher failure rates.
A clinical trial in 2019 tested the effectiveness of ONE condoms, manufactured by Global Protection Corporation, in 252 men who have sex with men and 252 men who have sex with women.